Showing Latest Articles
Initial Macular Thickness and Response To Treatment in Diabetic Macular Edema
Retina, 08/31/2011
Soheilian M et al. – In the primary treatment of diabetic macular edema, initial central macular thickness (CMT) may be an important factor in decision making. Regardless of initial CMT, intravitreal bevacizumab (IVB) caused a better visual outcome only at 6 weeks. With longer follow–up, however, IVB was superior to IVB/IVT and macular laser photocoagulation only in the eyes with initial CMT of ≥350micrometer. Concerning CMT reduction, this superiority of IVB in the eyes with initial CMT of ≥350micrometer was not observed beyond 12 weeks.
